🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Karen Li

ORCID: 0000-0002-0261-743X
Health ProfessionsMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.

12 citations

Sushmita Gordhandas, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman +12 more

4 citations

Shirley S. Sui, Karen Li, Patrick Low, Jonanne Talebloo, Iris Yuefan Shao +8 more

4 citations

Karen Li, Shirley S. Sui, Jonanne Talebloo, Christopher D. Otmar, Iris Yuefan Shao +6 more

1 citations

Kevyn L. Hart, Beatriz Campo Fernandez, Devin Brown, Kevin J. Tam, Andrea Gutierrez Garcia +14 more

0 citations

Christopher D. Otmar, Audrey Lopez, Angela E Kim, Shirley S. Sui, Karen Li +2 more

1 citations

Jiaqi An, Arum Yoo, Elle Fietsam, Caroline Booraem, Divya Reddy +11 more

N/A
0DataRank · unranked
5 citations

Karen Li, Angela E Kim, Iris Yuefan Shao, Christopher D. Otmar, Kyle T. Ganson +6 more